EXPRESSION PROFILING OF SKIN AND LUNG TISSUE AND EXPLANTED FIBROBLASTS IN A TRANSGENIC MOUSE MODEL OF SCLERODERMA
EC Derrett-Smith, CP Denton(The Royal Free Hospital), Rachel K. Hoyles(Royal Brompton Hospital), Pia Moinzadeh(University of Cologne), Khurram Ajaz Khan(IMC University of Applied Sciences Krems), Cecilia Beatrice Chighizola(University of Milan), Dietmar Abraham(Medical University of Vienna), Duu Sheng Ong
UCL Discovery (University College London)
October 1, 2011
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
|Lara D. Veeken|2008|287
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219